Bristol-Myers Squibb (BMY) April calls active into ISS expected to weigh in on Celgene deal soon

March 27, 2019 10:31 AM

Bristol-Myers Squibb (NYSE: BMY) March and April weekly call option implied volatility is at 30, April is at 31; compared to its 52-week range of 17 to 44 after CNBC's David Faber reported proxy advisory service ISS is expected to weigh in on the Bristol-Myers Squibb /Celgene (NASDAQ: CELG) deal soon. Call put ratio 2.5 calls to 1 put with focus on April 52 and 54 calls.



Next Articles